Takeda Pharmaceutical Company Limited
4502.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥6,968 | ¥6,507 | ¥6,750 | ¥5,469 |
| - Cash | ¥234 | ¥205 | ¥230 | ¥850 |
| + Debt | ¥5,089 | ¥5,463 | ¥4,862 | ¥4,811 |
| Enterprise Value | ¥11,822 | ¥11,765 | ¥11,383 | ¥9,430 |
| Revenue | ¥4,582 | ¥4,264 | ¥4,027 | ¥3,569 |
| % Growth | 7.5% | 5.9% | 12.8% | – |
| Gross Profit | ¥2,455 | ¥2,325 | ¥2,298 | ¥2,044 |
| % Margin | 53.6% | 54.5% | 57.1% | 57.3% |
| EBITDA | ¥1,127 | ¥928 | ¥1,185 | ¥1,043 |
| % Margin | 24.6% | 21.8% | 29.4% | 29.2% |
| Net Income | ¥108 | ¥144 | ¥317 | ¥230 |
| % Margin | 2.4% | 3.4% | 7.9% | 6.4% |
| EPS Diluted | 67.23 | 91.16 | 201.94 | 145.87 |
| % Growth | -26.3% | -54.9% | 38.4% | – |
| Operating Cash Flow | ¥962 | ¥640 | ¥877 | ¥1,021 |
| Capital Expenditures | -¥201 | -¥175 | -¥141 | -¥123 |
| Free Cash Flow | ¥762 | ¥465 | ¥737 | ¥898 |